Yukio Hirabayashi
Matsumoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura.
Journal: International journal of hematology
Published: June 18, 2019
STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.
Journal: International journal of hematology
Published: January 14, 2019
High-dose Dexamethasone Therapy as the Initial Treatment for Idiopathic Thrombocytopenic Purpura: Protocol for a Multicenter, Open-label, Single Arm Trial.
Journal: Acta medica Okayama
Published: April 21, 2018
Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial.
Journal: International journal of hematology
Published: October 24, 2017
Pulmonary Injury from Waterproofing Spray During a Hike.
Journal: Wilderness & environmental medicine
Published: April 03, 2017
Persistent Infection of Drug-resistant Influenza A Virus during Chemotherapy for Malignant Lymphoma.
Persistent Infection of Drug-resistant Influenza A Virus during Chemotherapy for Malignant Lymphoma.
Journal: Internal medicine (Tokyo, Japan)
Published: July 05, 2016
Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy.
Journal: Leukemia & lymphoma
Published: April 14, 2016
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.
Journal: International journal of hematology
Published: October 12, 2015
Kinetics of hematopoietic stem cells and supportive activities of stromal cells in a three-dimensional bone marrow culture system.
Journal: Growth factors (Chur, Switzerland)
Published: October 03, 2015
Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.
Journal: Leukemia & lymphoma
Published: September 22, 2015
Development of primary central nervous system lymphoma associated with human immunodeficiency virus and JC virus infection.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: December 16, 2014
Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
Journal: International journal of hematology
Published: November 26, 2014
Last Updated: 09/26/2026